Merck ‘bio-inks’ deal to use Organovo’s 3D printed liver for preclinical studies

Outsourcing-Pharma.com “Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing”